Connecting you to content on EBSCOhost

Works by Stetter, Isabelle

Results: 4

1

Evaluation of early metabolic changes following vorasidenib using FET PET in patients with IDH-mutant gliomas.

Published in:

Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae210

By:

Galldiks, Norbert;
Werner, Jan-Michael;
Stetter, Isabelle;
Puhr, Hannah C;
Nakuz, Thomas S;
Stoffels, Gabriele;
Albert, Nathalie L;
Langen, Karl-Josef;
Lohmann, Philipp;
Preusser, Matthias

Publication type:

Article

2

PET imaging of gliomas: Status quo and quo vadis?

Published in:

Neuro-Oncology, 2024, v. 26, p. S185, doi. 10.1093/neuonc/noae078

By:

Galldiks, Norbert;
Lohmann, Philipp;
Friedrich, Michel;
Werner, Jan-Michael;
Stetter, Isabelle;
Wollring, Michael M;
Ceccon, Garry;
Stegmayr, Carina;
Krause, Sandra;
Fink, Gereon R;
Law, Ian;
Langen, Karl-Josef;
Tonn, Joerg-Christian

Publication type:

Article

3

Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib.

Published in:

Neuro-Oncology, 2023, v. 25, n. 6, p. 1193, doi. 10.1093/neuonc/noad051

By:

Werner, Jan-Michael;
Wollring, Michael M;
Tscherpel, Caroline;
Rosen, Elena K;
Werr, Lisa;
Stetter, Isabelle;
Rueß, Daniel;
Ruge, Maximilian I;
Brunn, Anna;
Shughri, Abdulkader Al;
Kabbasch, Christoph;
Fink, Gereon R;
Langen, Karl-Josef;
Galldiks, Norbert

Publication type:

Article

4

MRI and <sup>18</sup>F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 838, doi. 10.2967/jnumed.123.266687

By:

Rosen, Jurij;
Werner, Jan-Michael;
Ceccon, Garry S.;
Rosen, Elena K.;
Wollring, Michael M.;
Stetter, Isabelle;
Lohmann, Philipp;
Mottaghy, Felix M.;
Fink, Gereon R.;
Langen, Karl-Josef;
Galldiks, Norbert

Publication type:

Article